Navidea Biopharmaceuticals OverviewNavidea Biopharmaceuticals Operating Income
Operating Income for NAVB.
Quarterly Operating Income
$-2131338.00
↓ 56.95% YoY
As of Sep 30, 2023
Annual Operating Income (TTM)
$-9996618.00
↓ 31.02% YoY
Trailing 12 months ending Sep 30, 2023